Startups channel feed

'A fourth rev­o­lu­tion in can­cer ther­a­pies': ARCH-backed Bound­less Bio flash­es big check, makes big­ger promis­es in de­but

6 years ago
Financing

Biotech boards bur­dened: Bridg­ing the suc­cess gap

6 years ago
Financing
Biotech Voices

Pre­clin­i­cal can­cer biotech IGM Bio­sciences sets stage for up­sized $175M IPO

6 years ago
Financing

Benev­o­len­tAI's lat­est fi­nanc­ing could halve its $2B val­u­a­tion — and that has Wood­ford watch­ers wor­ried

6 years ago
Financing
AI

Star founders, in­ves­ti­ga­tors hud­dle around new Boston ac­cel­er­a­tor spot­light­ing young en­tre­pre­neurs

6 years ago

Roche vet Jean-Jacques Ga­raud woos in­ter­na­tion­al be­liev­ers in his French star­tup's take on sep­tic shock

6 years ago
Financing

Strug­gling poo-test­ing start­up uBio­me files for bank­rupt­cy, months af­ter FBI kicks off in­ves­ti­ga­tion

6 years ago
FDA+

Ver­sant-backed pre­ci­sion on­col­o­gy start­up Re­pare Ther­a­peu­tics scores $82M+ in lat­est round

6 years ago
Financing

Nkar­ta maps out clin­i­cal, man­u­fac­tur­ing plans for CAR-NK fol­low­ing $114M round led by Sam­sara

6 years ago
Financing
Cell/Gene Tx

RA Cap­i­tal-backed cell ther­a­py play­er in the neoanti­gen game grabs a $121M megaround to fund first hu­man stud­ies

6 years ago
Financing

Ver­sant-backed Chi­nook gets a $65M launch round for its dis­cov­ery quest in a resur­gent kid­ney field

6 years ago
Discovery

Finch grabs a $53M round de­signed to take their ‘break­through’ mi­cro­bio­me treat­ment through a po­ten­tial­ly piv­otal tri­al

6 years ago
FDA+

Johns Hop­kins sci­en­tists raise $137M megaround for a trio of spin­outs look­ing to tack­le Alzheimer’s, Parkin­son’s and fi­bro­sis

6 years ago
Financing

Biotech tar­get­ing rare heart mu­ta­tion with gene ther­a­py scores $11M in Se­ries A haul

6 years ago
Financing
R&D

IBD start­up Lan­dos lands $60M Se­ries B in first test case of Chris Garabe­di­an's lean and mean mod­el at Xon­toge­ny

6 years ago
Financing

Alexan­dria seals $143M deal in Seat­tle's 'heart of the heart,' grab­bing cov­et­ed land to build its biotech clus­ter

6 years ago

Part pro­ce­dure, part drug: Robert Ang joins Sid­dhartha Mukher­jee in pi­o­neer­ing a new type of cell en­gi­neer­ing

6 years ago
People
Cell/Gene Tx

Biotech start­up joins quest to har­ness mi­cro­bio­me to un­teth­er re­liance on an­tibi­otics in wom­en's health

6 years ago

Backed by No­vo and Or­biMed, Thier­ry Abri­b­at hauls in $75M for biotech #3 — a transat­lantic up­start fo­cused on rare dis­eases

6 years ago
People

Laser-fo­cused on col­orec­tal can­cer test, Freenome wins $160M from mar­quee VC pack led by RA, Po­laris

6 years ago
Financing

No­var­tis backs Har­vard spin­out's quest to build TCR repos­i­to­ry in $48M round

6 years ago
Financing

Chardan's blank check com­pa­ny picks mi­cro­bio­me play­er Bio­mX for $70M re­verse merg­er

6 years ago

Backed by some of the biggest names in biotech, Nor­bert Bischof­berg­er gets his megaround for plat­form tech out of MIT

6 years ago
Financing

Bay­er, Long­wood back star re­searcher's deep dive in­to the tu­mor mi­croen­vi­ron­ment for new I/O tar­gets

6 years ago
Financing
First page Previous page 57585960616263 Next page Last page
A service from the Financial Times